Carlos Exconde

Mohammed Hussain and Carlos M. Exconde serve as Contracting Officers and Contract Specialists within the 261-NETWORK Contract Office 21 (36C261) of the Department of Veterans Affairs, where they lead the acquisition of critical medical infrastructure and clinical equipment to support veteran healthcare delivery. Their portfolio encompasses the procurement of surgical appliances, diagnostic instruments, laboratory systems, and related technical services essential to maintaining and modernizing VA medical facilities. They exercise full contracting authority under FAR and VA-specific guidelines, managing complex solicitations from market research through award and contract administration to ensure compliance, value, and mission alignment. Their primary contractor relationships include Abbott Laboratories Inc., Cynergy Professional Systems LLC, Integrated Trans Joint Venture LLC, Science Applications International Corporation, and McKenzie Construction & Site Development LLC. These partnerships reflect a focus on established industry leaders in medical device manufacturing, clinical systems integration, and facility modernization. Hussain and Exconde maintain consistent, performance-driven engagements with these vendors, leveraging long-term contractual frameworks to ensure reliable delivery of high-stakes medical and infrastructure solutions under stringent quality and regulatory standards. While the majority of their acquisitions—91.2%—are conducted without set-asides, they maintain a measurable commitment to small business participation, with 5.9% of awards designated as Total Small Business Set-Asides and 2.9% reserved for Service-Disabled Veteran-Owned Small Businesses. Their socioeconomic contracting patterns reflect a balanced approach: prioritizing mission-critical capability while actively supporting veteran-owned and small business vendors where feasible under competitive conditions. Their technical domain expertise centers on NAICS 339113 (Surgical Appliance and Supplies Manufacturing), which accounts for over 60% of their acquisitions, alongside related categories in medical instrument manufacturing and ophthalmic goods. They routinely procure Class II and III medical devices, surgical consumables, and diagnostic equipment, demonstrating deep familiarity with FDA-regulated procurement, clinical validation requirements, and lifecycle management of healthcare technology.